NCT01428362View on ClinicalTrials.gov

VI-1121 for the Treatment Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Alzheimer's Disease
Interventions
DRUG

VI-1121

DRUG

Placebo

Trial Locations (11)

12553

New Windsor

27612

Raleigh

27710

Durham

33351

Sunrise

40217

Louisville

43623

Toledo

75075

Plano

89113

Las Vegas

90404

Santa Monica

94109

San Francisco

08755

Toms River

Sponsors

Collaborators (1)

Medpace, Inc.
All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

lead

VIVUS LLC

INDUSTRY